Avaxim Use In Pregnancy & Lactation

Pregnancy: Avaxim 80 U Pediatric: No relevant teratogenic data on animal are available.
In humans, up to now, the data is inadequate to assess teratogenic or foetotoxic risk of the vaccine against Hepatitis A when administered during pregnancy.
As a precautionary measure, it is preferable not to use this vaccine during pregnancy except in case of a major contamination risk.
Avaxim 160 U: No reliable data are available on teratogenesis in animals.
To date, there are no sufficiently relevant clinical data available to assess a potential vaccine-related malformation or fetotoxic effect of the hepatitis A vaccine, when it is administered during pregnancy. As a precautionary measure, it is preferable not to use this vaccine during pregnancy except in case of a major contamination risk.
Breast-feeding: Avaxim 80 U Pediatric: The effect of administration of AVAXIM 80 U Pediatric during lactation has not been assessed. As AVAXIM 80 U Pediatric is inactivated, any risk to the mother or the infant is improbable. The benefits versus the risks of administering AVAXIM 80 U Pediatric during lactation should carefully be evaluated.
Avaxim 160 U: The effect of administering this vaccine during breast feeding has not been studied and its use during breast feeding is therefore not recommended.